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DOI: 10.1039/c0sm00041hTissue engineering strategies have been showing promising early results in articular cartilage lesions
repair. Hydrogels based on natural origin polymers as chitosan glycerol-phosphate (CGP) thermo-
sensitive formulation that can be implanted in a minimal invasive manner, represent a great promise as
injectable scaffold choice for cartilage tissue engineering, but it lacks in mechanical properties.
A different formulation, from which a firm texture gels results is, therefore, desirable.
In this work we first aim to investigate the suitability of CGP to produce an injectable thermosensitive,
pH-dependent solution, when combined with increasing concentrations of starch: 0.5% (I), 1% (II), and
1.5% (III). The data collected from the rheological measurements showed that the addition of starch to
the CGP did not alter the transition temperature and confirmed the heating inducing gelation of all
solutions, supporting the ability of these novel formulations to be applied as minimal invasive systems.
The evaluation of the dynamic mechanical analysis of the hydrogels showed an increase in the storage
modulus within increasing starch concentration, clearly demonstrating that best viscoelastic properties
were obtained with the novel chitosan-starch based solution. The incorporation of starch also improved
the degradation profile. All materials showed to be biocompatible through the cytotoxicity screening
in vitro. These data suggested the potential of novel thermo-responsive chitosan-starch hydrogels to be
used as injectable vehicles for cell delivery in cartilage tissue engineering applications.
In a second phase, the potential of chitosan-b-glycerophosphate (CGP) and chitosan-b-
glycerophosphate-1% starch (CST) hydrogels to induce chondrocytic differentiation and cartilage
matrix accumulation were evaluated, as well as the influence of starch in the chondrogenesis of
encapsulated adipose derived stromal (ADSC) cells. The ADSC were homogeneously encapsulated,
remained viable, proliferated, and maintained the expression of typical chondrogenic markers genes,
and deposited cartilage ECM molecules. Improved results were obtained within the novel CST
constructs. The overall data suggest that chitosan-b-glycerophosphate-starch hydrogels could be
considered for chondrogenic differentiation of adipose derived stromal cells for cartilage-engineered
regeneration using minimal invasive techniques.Introduction
Articular cartilage defects resulting from injury or osteochondral
diseases may lead to degenerative arthritis and affect the daily
living activities. The incidence of cartilage pathologies is
increasing each year, and consequently, more clinical procedures
to repair the damaged tissue are being executed. Recent advances
in therapeutic strategies have been showing encouraging results
and are now beginning to shape clinical practice. The regenera-
tion of cartilaginous tissue of better quality is due to the
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5184 | Soft Matter, 2010, 6, 5184–5195therapies and their different elements, by combining chondro-
genic cells, biomaterial scaffolds, and suitable culture
conditions.1–3
The selection of an appropriate scaffold is of extremely
importance, since it will act as a temporary three-dimensional
(3D) support for cell growth, differentiation and production of
extracellular matrix (ECM), providing the environment for the
chondrocytic phenotype maintenance or restoring, and thus
playing an important role in the new tissue formation.4,5 There
are a number of biomaterial options as a cell-carrying scaffold
for cartilage tissue engineering applications, which can be
natural, synthetic, or a combination of both. Many of these are
smart hydrogels that could potentially be injected throughout
a minimal invasive transplantation.6–10 Additionally these water
swellable networks exhibit higher water contents, and macro-
molecular structure similar to native tissue, making them an ideal
vehicle to transfer cells to articular defects.11,12
Chitosan (C) is an aminopolysaccharide derived from partial
depolymerisation and deacetylation of chitin found in the shells
of crustaceans, and has been widely suggested for many differentThis journal is ª The Royal Society of Chemistry 2010
hydrogel matrices in cartilage applications (Fig. 1A).13,14 In 2000,
Chenite and colleagues developed a new approach based on the
neutralization of chitosan by adding polyol-phosphate salts, such
as b-glycerophosphate (GP), to produce an injectable thermo-
sensitive, pH-dependent solution, which is liquid at physiological
pH and room temperature, and becomes a gel if heated at body
temperature.15–17 One of the drawbacks of using the chitosan-
glycerophosphate (CGP) system is the limited mechanical
properties of hydrogels. An alternative formulation that gener-
ates a more rigid texture gel would be advantageous.18–20 Starch
is a natural biodegradable material composed by two polymeric
carbohydrates, amylose and amylopectin (Fig. 1B). Cartilage
regeneration approaches have been implemented using starch-
based polymers due to their good biodegradable, biocompatible,
and processing versatility properties.21–24
In this work we first aim to investigate the suitability of CGP
as a cell delivery vehicle when combined with increasing
concentrations of starch: 0.5% (I), 1% (II), and 1.5% (III). The
mechanical behaviour of these new CGP-starch based
(CS) systems was characterized trough dynamical mechanical
analysis, and rheological studies in function of temperature were
also conducted. The internal morphology of the hydrogels was
assessed by low temperature scanning electron microscopy –
cryoSEM. Degradation behaviour and cytotoxicity evaluations
were also performed. In a second phase we intended to evaluate
the in vitro chondrogenic differentiation of adult adipose-derived
stromal cells (ADSCs) when encapsulated in CS hydrogel and
compare with the system without the introduction of starch.
Owing to some limitation in using autologous chondrocytes,
namely in isolating through invasive biopsies, and the dediffer-
entiation trend which limits the chondrogenesis capacity;25,26
many recent studies have been showing the potential and feasi-
bility of ADSCs as cell source for cartilage tissue engineering
applications.27–29 The ADSCs are multipotent cells with the
ability to express distinct phenotypes under defined appropriate
culture conditions, including the induction toward a chondro-
genic phenotype.30 The multipotency attribute, together with the
self-renewal, and division ability are along with the appealing
characteristics of these cells. Moreover, the adipose tissue is
routinely wide available and can be harvested easily fromFig. 1 Chemical structure of (A
This journal is ª The Royal Society of Chemistry 2010liposuction, yielding an abundant cell number after expansion
without loss of multipotentcy.31
In this study, we aimed to evaluate if the ADSCs could
differentiate into chondrocyte-like cells within a CS hydrogel and
maintain the chondrogenic phenotype in vitro. The chondro-
genesis was assessed by molecular, biochemical, and histological
techniques.
Experimental (materials and methods)
Preparation of chitosan-glycerolphosphate (CGP) and chitosan-
glycerolphosphate-starch (CS) hydrogels
A sterile chitosan-GP solution of 2% chitosan-135 mM disodium
b-GP was prepared by dissolving 200 mg of purified low
molecular weight chitosan (Sigma, DD of 80% measured by
NMR spectroscopy) in 6 mL filter-sterilized 70 mM HCl. This
solution was subjected to a 20 min autoclave sterilization, cooled
to 4 C, and 1 mL filter-sterile 1.35M GP (Sigma) was then
added. Separately, 50 mg (CS–I), 100 mg (CS-II), and 150 mg
(CS-III) of potato starch (Sigma, S2630) were dispersed in 3 mL
of water to obtain final starch concentrations of 0.5%, 1%, and
1.5% (w/v%), respectively. The solutions were autoclave sterilized
and mixed with the chitosan-glycerophosphate at 4 C. The CGP
system was obtained by adding 3 mL of autoclaved water. All the
solutions were allowed to solidify for 20 min in a humidified, 5%
CO2 cell culture incubator at 37
C.
Rheological characterisation of thermogelling solutions
Rheological measurements of the 4 different hydrogel conditions
were conducted on a Stress-Tech HR controlled tension
rheometer (Reologica Instruments AB, Sweden), with parallel
plates (F 40 mm), requiring about 3 mL of solution as the sample
volume. The values of the strain amplitude were chosen in order
to ensure that all measurements were performed within the linear
viscoelastic region. The storage modulus (G0) and loss modulus
(G0 0) were measured as functions of temperature, under oscilla-
tion measurements of 1 Hz (1 rad s1) and constant stress of
10 Pa. The gap between the plates was 1 mm. The temperature
was varied, at a rate of 1 C min1, from 20 to 50 C. The gelation) chitosan, and (B) starch.
Soft Matter, 2010, 6, 5184–5195 | 5185
point is considered as the temperature at which both G0 and G0 0
crossover (tan d ¼ 1).
Low temperature scanning electron microscopy – CryoSEM
Cryogenic scanning electron microscopy was used to evaluate the
inner microstructure of the hydrogels. CryoSEM was conducted
on CEMUP SE equipment. The samples were placed in
a chamber, fractured and sublimated for 10 min at 95 C.
Fourier-transform infrared spectroscopy – FT-IR
The chemical composition of potato starch (Sigma, S2630) was
evaluated by fourier-transform infrared spectroscopy (FTIR)
using FTIR-IR Prestige-21 (Shimadzu). Prior analysis, trans-
parent sample/KBr discs (ratio 1 : 10) were prepared by uni-
axially pressing. Transmission spectra were recorded in the
spectral range of 4000–500 cm1 using at least 32 scans with
4 cm1 resolution.
Dynamic mechanical analysis – DMA
The viscoelastic measurements were performed using a TRI-
TEC8000B DMA from Triton Technology (UK), equipped with
the compressive mode. All hydrogel conditions were prepared as
described previously and were cut in cylindrical shapes with
about 6 mm diameter and 4 mm thickness. The geometry of the
samples was then measured and the samples were clamped in the
DMA apparatus and immersed in the PBS solution. Hydrogels
were always analyzed immersed in a liquid bath of PBS placed in
a Teflon reservoir and the measurements were carried out at
37 C of temperature. After equilibration, the DMA spectra were
obtained during a frequency scan between 0.1 and 10 Hz. The
experiments were performed under constant strain amplitude
(50 mm). A small preload was applied to each sample to ensure
that the entire hydrogel surface was in contact with the
compression plates before testing. Three samples were used for
each condition.
In vitro enzymatic degradation study
The hydrogels were incubated in phosphate buffered saline (PBS)
solution (pH 7.4) containing a-amylase (150 U L1 and lysozyme
(13 mg L1) at concentrations similar to the ones found in human
serum,32,33 at 37 C up to 60 days, in order to carry out the
degradation studies. At different time points, the samples were
removed and weighed. The weight loss (%W) was calculated
according to the following equation: %W ¼ mf mi
mi
 100,
where the mi and mf are the weight of the samples before and
after immersion in the enzymatic degradation solutions.
In vitro cytotoxicity screening on materials’ extracts
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium) test was performed to deter-
mine the cytotoxicity of chitosan-starch hydrogels leachables
that might result from the gelation methodology accordingly to
ISO/EN 10993-5. The CGP, CS–I, CS-II, and CS-III hydrogels
were prepared as described above, and allowed to become a hard
gel at 37 C. Then they were incubated in Dulbecco’s Modified5186 | Soft Matter, 2010, 6, 5184–5195Eagle’s Medium without phenol red (DMEM, Sigma) for 24 h at
constant temperature (37 C) and agitation (60 rpm) in order to
obtain the extract of the different materials containing potential
toxic leachables and degradation products. The ratio of materials
weight to extract fluid was constant, and equal to 0.2 g mL1.
Mouse fibroblastic-like cells (L929 cells; ECACC, UK), were
cultured in the same medium and were seeded in 96-well cell
culture plates (10 000 cells cm2), in order to reach 80% conflu-
ence in 24 h. The extracts were then filtered and placed in contact
with the monolayer of L929 cells for 24 h, 4 days, and 7 days. At
each time the viable cells, those with functional mitochondrial
dehydrogenase, able to reduce the yellow substrate into a brown
formazan product were determined by the MTS assay (CellTiter
96 One solution Cell Proliferation Assay kit; Promega, Madison,
WI). The optical density (OD) was read at 490 nm with a plate
reader (Synergy HTi, Bio-tek) and compared with the positive
control—latex extracts, and negative control—tissue culture
polystyrene (TCPS), for cell death.Chondrogenesis of human adult adipose derived stromal cells
(ADSC) encapsulated in CST hydrogel
ADSC isolation, expansion and encapsulation. Human adipose
stromal derived adult cells (ADSCs) were isolated from subcuta-
neous lipoaspirated adipose tissue, donated from consenting
patients at the Prelada Hospital - Porto, as previously described.34
Briefly, liposuction waste tissue was digested with 0.15% collage-
nase type II (Sigma) for about 1 h at 37 C under continuous
shaking. The floating adipocytes were separated from the precip-
itating stromal fraction by centrifugation. The stromal cells were
then plated in tissue culture flasks in basic DMEM-F12 medium
(Invitrogen) with 10% foetal bovine serum (FBS, Gibco), and
antibiotic-antimycotic (1% A/B, Gibco) solution containing
10 000 units mL1 penicillin G sodium, 10 000 mg mL1 strepto-
mycin sulfate and 25 mg mL1 amphotericin B as Fungizone in
0.85% saline, at 37 C in an atmosphere containing 5% of CO2 until
achieving confluence. Cells were cultured until passages 1 and 2, at
a confluence of more than 80%, after which they were harvested
with trypsin/EDTA, counted, and then mixed gently at room
temperature in the hydrogels solutions at a concentration of 10
million cells mL1. The chitosan-b-glycerophosphate (CGP) and
chitosan-b-glycerophosphate-1% starch (CST) solutions were
prepared as described above, and the cell suspension, within the
different formulations, were then dispensed into 6 mm diameter
moulds containing 200 mL of hydrogel solution per insert, allowed
to gel at 37 C for 20 min, then cultured in chondrogenic medium
composed of DMEM-F12 basic medium containing 1 nM dex-
ametasone (Sigma), 0.1 M sodium pyruvate, 37.5 mg mL1 of
ascorbate-2-phosphate (SIGMA), 35 mM proline, and 1 insulin-
transferrin-selenium (ITS+, Sigma), supplemented with
10 ng mL1 of transforming growth factor-b1 (PrepoTech, UK),
and 10 ng mL1 of fibroblast growth factor-2 (PrepoTech, UK), in
a humidified incubator at 37 C under 5% CO2 atmosphere for up
to 28 days, with medium changed every 3 days.Biochemical composition
The constructs were collected after 1, 14, and 28 days of culture,
washed twice with a sterile PBS solution, and then stored atThis journal is ª The Royal Society of Chemistry 2010
Table 1 The specific primer sets, nucleotide sequences, and annealing
temperatures for GAPDH and marker genes: collagen type I (Col I),
collagen type II (Col II), Aggrecan, and Sox 9
Gene name Primer sequence Annealing T/C
Col I f 50 – AGC CAG CAG ATC GAG
AAC AT – 30
58.4
r 50 – ACA CAG GTC TCA CCG
GTT TC – 30
Col II f 50 – CGG TGA GAA GGG AGA
AGT TG– 30
60.4
r 50 – GAC CGG TCA CTC CAG
TAG GA – 30
Aggrecan f 50 – CAG AGT TCA GTG GGA
CAG CA – 30
59.4
r 50 – AGA CAC CCA GCT CTC
CTG AA – 3080 C. When defrosted, samples were digested overnight at
56 C with protease K in 50 mM Tris with 1 mM EDTA, 1 mM
iodoacetamide and 10 mg mL1 pepstatin-A.
Cell proliferation was determined using a fluorimetric double
strand DNA (dsDNA) quantification kit (PicoGreen, Molecular
Probes). The fluorescence was measured using an emission of
490 nm and an absorbance wavelength of 520 nm in a plate
reader (Synergy HTi, Bio-tek).
The sulfated glycosoaminoglycans (GAGs) content was
measured spectrophotometrically using dimethylmethylene blue
(DMB, Sigma) assay based on the method described previ-
ously.35 Chondroitin sulfate (Sigma) was used as standard solu-
tion, and the optical density was read at 525 nm in a plate reader
(Synergy HTi, Bio-tek).Sox 9 f 50 – TTC ATG AAG ATG ACC
GAC GA – 30
58.4
r 50 – TGC CAG TCG TAG CCC
TTG AG – 30
GAPDH f 50 – ACA GTC AGC CGC ATC
TTC TT – 30
58.4
r 50 – GAC AAG CTT CCC GTT
CTC AG – 30Histological analysis
Cell morphology and distribution within the constructs were
examined by microscopy during the in vitro culture. Prior to
histological studies, the constructs were fixed in 2.5% v/v para-
formaldehyde for 24 h at 4 C, included in HistoGel (Thermo
Scientific), processed and paraffin embedded. Five micrometres
sections were cut and mounted onto positively charged slides.
The sections were stained with Hematoxilyn-Eosin (H&E) and
Toluidine Blue for proteoglycans, following standard histolog-
ical methods, and then examined microscopically and photo-
graphed.RNA extraction and analysis by real-time reverse
transcriptionpolymerase chain reaction–real time RT-PCR
(collagen type II, type I, aggrecan, and Sox 9)
The real-time RT-PCR analyses were performed after 1 and 4
weeks of culture to quantitatively assess the up- and down-
regulation of genes typically associated with chondrogenesis.
Total RNA was extracted using Tryzol reagent (Invitrogen).
Briefly, the samples were collected and the cells were lysed,
centrifuged at 13 000 rpm, 4 C for 15 min in the presence of
chloroform (Sigma), and RNA precipitated by the addition of
isopropanol (Sigma). After centrifugation (13 000 rpm, 4 C for
15 min), the RNA was washed in ethanol, dried and recon-
stituted in distilled water DNase, RNase free (Gibco). The
amount of isolated RNA and A260/280 ratio was determined
using NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies). Subsequently, the total RNA extracted was
reverse transcribed into cDNA using the iScript cDNA
Synthesis Kit (BioRad), following the manufacturer’s protocol.
Real-time PCR was performed in the MJ Mini Personal
thermal Cycler (BioRad) using 1 mg of each sample. The
expression of the genes of interest—collagen type I, collagen type
II, aggrecan, and Sox-9, was evaluated using MJ Opticon
Monitor 3.1 software (BioRad), and the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used
to normalize the marker gene expression. All primer sequences
were generated using Primer3 software, and acquired from
MWG (Biotech). The specific primer sets, nucleotide sequences
and product size, and annealing temperatures for GAPDH and
marker genes are summarized in Table 1.This journal is ª The Royal Society of Chemistry 2010PCR reactions were incubated for 5 min at 95 C, followed by
45 cycles were used for all genes, each one consisting of: dena-
turation (95 C, 10 s), annealing of 30 s (annealing temperature as
shown in Table 1), and chain elongation: (72 C, 30 s), followed
by denaturation (95 C, 1 min).
For each sample, the fluorescent cycle threshold (Ct) values
were determined automatically by the software and the relative
transcript levels were calculated using 2DDCt.36
Statistical analysis
Statistical analysis was performed using one-way analysis of
variance (ANOVA) and Tukey post-hoc to determine the
statistical significance as a function of culture time. A p value
< 0.05 was considered statistically significant for 95% of confi-
dence. Data are reported as mean  standard variation.
Results and discussion
Preparation of chitosan-glycerolphosphate (CGP) and chitosan-
glycerolphosphate-starch (CS) hydrogels
The minimal invasive injectable techniques using smart hydro-
gels as cell delivery system offers attractive features for cartilage-
engineered applications.6,10,37,38 The thermally sensitive,
pH-dependent chitosan polyol salts solutions, first reported by
Chenite et al.,15 have been proposed as a treatment modality for
a wide-ranging of applications that involves scaffold guided and
cell delivery regenerative medicine.39,40 Our group has also been
developing natural origin biomaterials for an ample range of
engineered applications, such as chitosan and starch-based
systems.22,41 Starch blending with biodegradable polymers, such
as chitosan, may improve the materials water resistance and
mechanical properties.42,43 Herein, chitosan-glycerophosphate
solutions were mixed with increasing concentrations of starch
solutions: 0.5%, 1%, and 1.5%, to produce CS hydrogels I, II, III,
respectively. All the systems have shown to be a solution at roomSoft Matter, 2010, 6, 5184–5195 | 5187
temperature, but gels are formed around physiological temper-
ature and pH, with similar gelation rates among all conditions.
The solutions’ colour changed from transparent to opaque upon
heating, and no visual differences were observed in the hydrogels’
appearance (data not shown).Rheological characterisation of thermogelling solutions
It was previously reported that chitosan solutions could be
neutralised up to physiological pH using b-GP salts, undergoing
a thermal gelation upon heating.15,16
The ability of the different solutions to become a gel after
heating was studied by rheological measurements. The storage
modulus (G0) and the loss modulus (G0 0) were measured as
function of time from room temperature to 50 C. Fig. 2 shows
the evolution of G0 and G0 0 moduli of the sample CGP, CS–I,
CS-II and CS-III upon heating, temperatures ranging from room
temperature to 50 C.
In all cases, similar fashion curves were observed that can be
described in three different regions, as it was previous demon-
strated.44,45 In the first region, a common viscoelastic fluid-like
behaviour of polymer solutions is detected, were increasing the
temperature both storage and loss moduli decreased, being G0 0
> G0. The second region is characterized by an abrupt increase in
both G0 and G0 0 moduli because of the sol–gel transition
(establishment of hydrogel three-dimensional network). The
storage modulus growth rate was also expected to be higher,Fig. 2 Rheological results showing the evolution of storage, G0 and loss, G0
heating from 20 to 50 C.
5188 | Soft Matter, 2010, 6, 5184–5195indication of increasing elasticity in the system, than of the loss
modulus due to the gel formation process. The gelation
temperature was considered as the point at which both G0 and
G0 0 crossover (tan d¼ 1).44 In all cases the transition temperature
were found near below the body temperature, ranging from
36.3 C in CS–I and 36.9 C in CS-III hydrogels.
These results showed that the addition of starch to the chito-
san-GP solution did not alter the transition temperature and
confirmed the heating inducing gelation of all solutions, which
remain liquid at room temperature and solidifies into white
hydrogels near body temperature. The low viscosity values
(Fig. 3) of these novel chitosan-starch-based hydrogels allowed
us to prepare a homogeneous cell suspension at room tempera-
ture to be used as injectable delivery system through a minimal
invasive procedure for cartilage regeneration.Low temperature scanning electron microscopy – cryoSEM
The ultrastructure and morphology of the hydrogels were
observed trough cryoSEM. The CGP hydrogel was previously
characterized and had shown to form an open homogeneous
porous network composed of chitosan where GP is unbounded
and freely dispersed. Also in previous studies, SEM based tech-
niques revealed a uniformly porous mesh-like structure, where
a continuous network, with a few micrometres-thick, is
surrounding the porous.17,46 The cryoSEM allows the assessment
of the sub-micro structure of the gels giving images with higher0, moduli of samples: (A) CGP (B) CS–I, (C) CS-II and (D) CS-III upon
This journal is ª The Royal Society of Chemistry 2010
magnification then normal SEM techniques. Fig. 4A shows
a typical overall appearance of CGP hydrogel where it is possible
to see an open and beaded-like network structure, constituted by
linking polymeric clusters assembled in agglomerates and chains.
This structure provides a uniform matrix in which cells can be
encapsulates in a rather uniform way. The hydrogels containing
starch led to structures with similar morphologies although
the network appeared to be more open in the starch ones
(Fig. 4B–D). This less dense matrix, compared with CGP
condition, was found among all CS systems, and the addition of
increasing concentrations of starch did not produce considerable
changes in the morphology of the starch based hydrogels.
Although further studies will be need to explain this particular
feature in the CS scaffolds, it can be related with the hydrophi-
licity of starch which augments the water retention in new
developed hydrogels, and thus creating this more open network
structure.Fig. 4 CryoSEM images of the surface fracture of (A) CGP, (B) CS–I,
(C) CS-II and (D) CS-III hydrogels in two different magnifications.Dynamical mechanical analysis – DMA
The clinical success of tissue-engineered constructs is highly
related with the mechanical properties of the engineering
constructs, which should match the tissue intended to be regen-
erated.47,48 Cartilage clearly exhibits viscoelastic properties and
their mechanical response is mainly related with the solid
components of the extracellular matrix (ECM), such as proteo-
glycans and collagens, but also strongly tied to the flow of fluidFig. 3 Viscosity of: (A) CGP (B) CS–I, (C) CS-II and
This journal is ª The Royal Society of Chemistry 2010through the tissue.49 Therefore the characterization is of extreme
importance for the solid-state rheological behaviour of the
materials performed at physiological conditions to predict their
mechanical performance in vivo. Generally the mechanical(D) CS-III solutions as function of temperature.
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properties in the hydrated state are acquired using samples
previously wetted and measured in conventional equipment, but
we believe that this is not enough and, therefore, in this work, the
hydrogels were analysed with experimental data taken in physi-
ological simulated solutions, i.e. the samples were totally
immersed PBS, at body temperature, 37 C, during the
measurements.
Dynamic mechanical analysis, DMA, is a non-harmful tech-
nique in which the sample is subjected to an oscillatory stress and
the follow-on strain is measured in function of a wide range of
temperature and frequencies. DMA methods enable the accurate
quantification of the viscoelastic properties of a variety of scaf-
folds for biomedical applications.50–52
Fig. 5 shows the isothermal DMA response of CGP and CS–I,
CS-II and CS-III hydrogels as a function of frequency in terms of
storage modulus (E0) and loss factor (tan d). The elastic
component (E0) is related with the stiffness of the material, while
E0 0 (the viscous component) is associated with the dissipation of
energy, as heat, due to internal friction at the molecular level.
The loss factor, tan d, is defined as the ratio E00/E0.
It was observed, for all the compositions, that the storage
modulus (E0) tends to increase with increasing frequency
(Fig. 5A). It was also observed that the elastic modulus increased
significantly with the addition of higher concentrations of starch,
indicating that the presence of starch improved the stiffness of
the hydrogels materials (5.5  104 Pa for CGP and 2.0  105 Pa
for CS-III). The higher stiffness was observed in the formulation
with higher concentration of starch CS-III (Fig. 5A). Fig. 5B
shows that tan d decreases within the CS formulations with
increasing frequency with values typically higher than 0.2,
evidencing the clear viscoelastic nature of the structures.
Although these values are not optimal comparing the articular
cartilage mechanical functions,53,54 they are in the same range of
values found for other hydrogels proposed for cartilage tissue
engineering approach.7,46 Furthermore, the cell encapsulation
and ECM accumulation may result in a biomechanical
improvement. Comparing with the chitosan basic system, these
results clearly demonstrated that best viscoelastic properties were
obtained with novel hydrogel starch-based formulations.
Three types of interactions are involved in the gelation process
of CGP system: (1) electrostatic attraction between theFig. 5 Dynamic mechanical analysis of CGP and CS hydrogels as a function o
5190 | Soft Matter, 2010, 6, 5184–5195phosphate group of GP and the ammonium groups of chitosan;
(2) hydrogen bonding between polymer chains as a result of
reduced electrostatic repulsion after neutralization of the chito-
san solution with GP; and (3) chitosan–chitosan hydrophobic
interactions.46
It was also demonstrated that the sol–gel transition occurs in
two steps. Initially, the addition of a weak base, such as GP, will
partially neutralize the polyelectrolyte chitosan and bring the
solutions close to precipitation. Thereby, when heated, chitosan
is induced to release its protons, which will be transferred to
glycerol phosphate, thus allowing the attractive electrostatic
interchain forces to promote chitosan precipitation and induce
the sol–gel transition.55,56 As a result, a physically cross-linked
hydrogel is formed.
The improved mechanical properties observed in the novel
formulations containing starch may be explained by several
possible interactions, although complementary studies will be
necessary to establish the exact mechanisms involved. Starch is
composed by amylose molecules which are essentially linear
a(1/ 4)glucan chains, and by amylopectin molecules which are
highly branched and often contain small amounts of covalently
bound phosphate. Potato starch is characterized by a high
content of phosphate relative to other starch sources.57
FT-IR spectroscopy was used to confirm the presence of
phosphate groups in the chemical structure of potato starch used
to prepare the hydrogels. Several characteristic absorption bands
of starch were identified in Fig. 6, such as C–O, C–H, and
hydroxyl groups stretching vibration. Compared with native
starch, the spectrum of potato starch showed a three new bands
at 1168, 1088, and 918 cm1, which were ascribed to P]O,
C–O–P, and O–P–O of the phosphate group, respectively.58 The
appearance of these bands could be considered as an evidence for
the occurrence of phosphate groups in starch.
The presence of these anionic groups may act as a proton sink,
in a similar way observed on GP, and thus enhancing the elec-
trostic attraction between the ammonium groups of chitosan and
the phosphate groups of both GP and starch. The hydrophilic
properties of starch might also contribute for the reinforcement
in the mechanical properties of these CS formulations due to the
ability to uptake water, raising up the rheological behavior of the
starch-based hydrogels.f frequency in terms of storage modulus, E0 (A), and loss factor, tan d (B).
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Fig. 6 FT-IR spectrum of potato starch containing phosphate groups.
Fig. 7 Weight loss of CGP and CS hydrogels as function of time in PBS
with a-amylase (150 U L1) and lysozyme (13 mg L1).
Fig. 8 Cytotoxicity screening for the CGP and CS hydrogels, positive
control (latex rubber), and negative control (TCPS) extracts, incubated
with L929 cells for 1, 4, and 7 days.Degradation behaviour – in vitro enzymatic degradation study
Biomaterial degradability is an important criterion for achieving
optimal tissue regeneration with cell transplantation. The scaf-
folds should maintain its structural and mechanical integrity for
long periods of time until the growing cartilage can support itself,
hence they should degrade at a rate in line with the new tissue
regeneration. A slow degradation profile can inhibit the tissue
function, while a fast degradation can influence cell distribution
and migration, as well as ECM deposition.3 There are a number
of factors that influence the hydrogel degradation, such as
hydrogel chemistry, crosslinkage, presence of cells and in vivo
environment.9 Therefore, the in vitro degradation studies should
be performed in simulated physiological environment.
In this work we propose a new set of hydrogel formulations
based on two biodegradable materials: chitosan and starch. The
degradation of chitosan in the human body is carried out
primarily by lysozyme, an enzyme that destroys bacteria through
cell wall disruption by catalysing hydrolysis of proteoglycans.59
In the human body, lysozyme is found in different body fluids
and is part of the innate immune system, playing in this way, an
important role following implantation of biomaterial. The in vivo
degradation products of chitosan are non-toxic and non-immu-
nogenic.
Starch is also known to be susceptible to enzymatic degrada-
tion. Many enzymes may be involved in starch degradation,
among them a-amylase, which is also found in human fluids.33
The main aim of studying the degradation behaviour using
enzymes with similar concentration found in human serum is to
simulate the physiological conditions.32 For that purpose,
hydrogels were incubated with an enzyme cocktail containing
a-amylase (150 U L1) and lysozyme (13 mg L1) in PBS and
their weight loss was followed over 60 days. In all the hydrogel
conditions, it was possible to detect a gradual increase in weight
loss (Fig. 7). An enhanced degradation rate was distinguished in
all the starch-based formulation when compared with a CGP
hydrogel, although no significant differences were observed in
the degradation profile within the starch samples. It seems that
the incorporation of starch in the formulations increased the
degradation rate, but the selected concentrations were not high
enough to observe between the CS–I, CS-II, and CS-III systems.
The combination of starch within chitosan-based hydrogel
renders an improvement in the mechanical properties andThis journal is ª The Royal Society of Chemistry 2010degradation profile, suggesting the potential of these novel
thermo-responsive hydrogels to be used as an injectable scaffolds
for cartilage engineered applications.In vitro cytotoxicity screening on materials’ extracts
The biocompatibility of the developed systems is, as well, as issue
of great importance. A cytotoxicity test was performed using the
extracted leachables from hydrogels, where L929 cells were
exposed to the degradation product release by those materials
after immersion in culture medium and cultured up to 7 days.
The viability MTS assay was performed and the cells show
similar metabolic activities to those obtained by the negative
control for cell death (tissue culture polystyrene - TCPS). The
effects of the positive control (latex) were evident, conferring
a strong decrease in cell viability as shown in Fig. 8. Therefore
the leachables released from the hydrogels could be considered as
noncytotoxic towards mouse fibroblasts cell line. This is in
accordance with a previous study that had shown the biocom-
patibility of CGP hydrogels.60
In the present study, a novel chitosan-starch based set of
hydrogels was proposed as vehicles for cell delivery in cartilage
tissue regeneration. The data collected from rheological analysis
confirmed that these new formulation exhibit an ability to be
applied as a minimal invasive systems: the low initial viscosity of
the solution allows the efficient distribution of the cell, togetherSoft Matter, 2010, 6, 5184–5195 | 5191
with the formation of a stable hydrogel with entrapped cells
when reached the body temperature. Improvements in the
mechanical properties and degradation rates were also registered,
corroborating the potential of these novel cell delivery systems
for cartilage engineered treatments.
The succeeding cell encapsulation studies towards chondro-
genesis were performed with the CS-II formulation, which will be
named from now on as CST.Chondrogenesis of human adult adipose derived stromal cells
ADSC encapsulated in CST hydrogel
In a second phase of this study, we aim to evaluate the potential
of chitosan-b-glycerophosphate (CGP) and chitosan-b-glycer-
ophosphate-1% starch (CST) hydrogels to induce chondrocytic
differentiation and cartilage matrix accumulation of ADSCs. We
also intend to explore whether the enhanced biomechanical
properties of the starch formulation, above mentioned, might
influence the chondrogenesis of the encapsulated ADSC cells.
During the last years, researches have been seeking novel
chondrogenic cell sources, in a more abundant supply than
chondrocytes, to promote articular tissue regeneration. The
potential of stromal cells isolated from human adipose tissue
(i.e., subcutaneous fat), to differentiate into a chondrocytic
phenotype under defined culture conditions, either with or
without cell laden scaffolds, has been evaluated in diverse
studies.27,29,30Biochemical composition
After isolation and expansion, 10 million cells were encapsulated
in CGP and CST and cultured in chondrogenic medium. The
biochemical composition of the constructs was determined to be
dependent on time in culture (Fig. 9).
The total DNA content was evaluated using a fluorimetric
dsDNA quantification kit (PicoGreen, Molecular Probes). The
DNA gradually and significantly increased during the 4 weeks of
culture in both hydrogel conditions, and reached values of
3.66 mg DNA/construct in the CGP and 5.78 mg DNA/construct
in CST gel (Fig. 9A). These data indicated that ADSC afterFig. 9 ADSC cells proliferation when encapsulated in CGP and CST hydroge
of DNA in the constructs. (* p<0.05.)
5192 | Soft Matter, 2010, 6, 5184–5195expansion, and once seeded within the thermoresponsive mate-
rials, maintain a proliferation potential and remain viable.
Although the DNA values were similar in the firth 2 weeks of
culture for both conditions, the DNA values were significantly
higher in the starch-based constructs after 28 days of culture
(Fig. 9A).
The sulfated glycosoaminoglycans (GAGs) are essential
elements in native extracellular matrix. They have an important
role in the tissue mechanical response, by enabling cartilage to
bind water and account for the property of compressive stiffness
that is crucial for the correct function of articular joints.61,62
GAGs were quantified using dimethylmethylene blue (DMB)
assay. The assay is based on the ability of sulfated glycosami-
noglycans to bind the cationic dye 1,9-dimethylmethylene blue.
It is formed a glycosaminoglycan/dye complex, and the optical
density measurement of the dissociated dye permitted quantifi-
cation of glycosaminoglycans in biological samples.
The results of the assay revealed that the all the constructs
exhibited an increase in proteoglycan accumulation (Fig. 9B).
It is also noticeably evident that the GAGs level normalized to
total DNA of ADSC/CST constructs were much higher that
those of ADSC/CGP constructs. These results indicate that CST
hydrogel allowed three-dimensional culture of ADSC able to
synthesize a GAG-containing ECM, and gathers unequivocally
an improved biochemical composition.Histological analysis
Cell morphology and distribution within the constructs were
examined by microscopy during the in vitro culture. H&E
histological staining revealed that the cells were uniformly
distributed throughout the whole hydrogel and adopted a typical
rounded morphology of native chondrocytes (Fig. 10A-B). This
round-shaped morphology is one of the characteristics of the
differentiated chondrocytic phenotype,63,64 which allows
synthesis of cell-specific pericellular or intercellular matrix. The
differentiated phenotype, together with the cell viability and
distribution are important aspects to take into account when
preparing tissue engineering implants.ls (A), and sulfated glycosaminoglycan content normalized to the amount
This journal is ª The Royal Society of Chemistry 2010
Fig. 10 H&E histological sections of the CGP (A) and CST (B); and
Toluidine Blue histological sections of the CGP (C) and CST (D)
constructs taken after 28 days of culture.Of utmost importance is also the accumulation of cartilage-
specific macromolecules in the constructs to form an ECM
similar to the native one.65 Sulfated glycosaminoglycans were
detected in histological sections of the constructs after 4 weeks
of culture using Toluidine Blue metachromatic stainingFig. 11 Graphical representation of the realtime semiquantitative PCR anal
based on the mRNA produced by the encapsulated ADSC after 1 and 4 wee
This journal is ª The Royal Society of Chemistry 2010(Fig.10C-D). The positive staining was localized in the peri-
cellular and extracellular regions throughout the hydrogels,
although the metachromasia (indicative of cartilaginous matrix)
was more evident in the starch constructs (Fig. 10D). The iden-
tification of proteoglycans in the ECM are in agreement with,
and reinforce the previous results of the biochemical quantifi-
cation of GAGs, being a positive indicator towards the
formation of cartilage-like tissue.Real-time RT-PCR (collagen type II, type I, aggrecan, and Sox 9)
The real-time RT-PCR analysis were performed after 1 and 4
weeks of culture to quantitatively assess the up- and down-
regulation of genes typically associated with chondrocytes and
cartilage tissue formation. The analysis of Sox 9, collagen I,
collagen II, and aggrecan genes were performed, normalized to
GAPDH housekeeping expression and the comparative 2DDCt
(Livak) method was used to analyse the results.
Collagen type II, IX, X and XI are traditionally considered
specific for cartilage, and they are present at different stages of
chondrogenic process. Collagen type II is involved in weight
bearing and adsorbing functions and is the major protein
produced by chondrocytes in articular cartilage.48,63 Aggrecan is
also one of the most important components of ECM, being the
main proteoglycan, and its primary function is to give visco-
elastic compressive properties to the cartilage. The expression ofysis for aggrecan (A), collagen type II (B), collagen type I (C), Sox 9 (D)
ks of culture (* p<0.05).
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Sox 9 is the first step towards chondrogenesis and is responsible
for the expression of some key genes, thus regulating some
important events throughout chondrogenesis. Hence, the detec-
tion of Sox 9, collagen type II, and aggrecan are positive indi-
cators of the hyaline-like nature of tissue engineered constructs.
Collagen type I is associated with the dedifferentiation process
and it is a characteristic feature of chondrocytes grown in two-
dimensional cultures. It is well known that during monolayer
expansion, the chondrocytes adopt a more fibroblast-like
morphology, accompanied by the up-regulation of type I
collagen expression, and thus its presence is a poor indicator of
an articular ECM-like matrix.48
The graphical representation of the molecular expression
(Fig. 11) shows that collagen type I levels were residual after one
and four weeks of culture either in CGP and CST hydrogels.
In both conditions there was a significant increase in collagen
type II, Sox 9 and aggrecan. The upregulation profile of these
genes was higher on the CST constructs when compared with
CGP at week 4. The increase in collagen type II in CST was more
than 30 fold greater than in CGP hydrogels; and17 fold greater
in both aggrecan and Sox 9, after 28 days of culture. The real-
time RT-PCR suggested that ADSC were undergoing chondro-
genic differentiation, by the expression and deposition of ECM
components.
These analyses strengthened the ability of these thermores-
ponsive hydrogels to induce and support the chondrocytic
differentiation of adipose derived stromal cells in vitro, with
a significant enhancement in the novel CST construct towards
a development of an hyaline like tissue.Conclusions
Novel formulations based on chitosan-b-glycerophosphate and
the combination of starch, were proposed as thermoresponsive
injectable systems for cell delivery and support, aiming cartilage
regeneration through engineered strategies.
The rheological measurements showed that the addition of
starch to the chitosan-GP solution did not alter the transition
temperature and confirmed the heating inducing gelation of all
solutions, which remain liquid at room temperature and solidifies
into white hydrogels near body temperature, supporting the
ability of these formulations to be applied as a minimal invasive
systems. The evaluation of the dynamic mechanical analysis of
the hydrogels showed an increase in the storage modulus within
increasing starch concentration, clearly demonstrating that
better mechanical behavior could be obtained with novel
hydrogel formulations. The incorporation of starch also
improved the degradation profile. All the conditions showed to
be biocompatible through the citotoxicity screening in vitro.
Added together these data suggested the potential of these novel
thermo-responsive chitosan-b-glycerophosphate hydrogels
to be used as an injectable scaffolds for cartilage engineered
applications.
In a second phase of this study, we demonstrated the suit-
ability of chitosan-b-glycerophosphate (CGP) and chitosan-b-
glycerophosphate-1% starch (CST) hydrogels to promote
differentiation of ADSCs and maintained the chondrogenic
phenotype. The cells were homogeneously encapsulated, remain
viable, proliferated, and maintained the expression of typical5194 | Soft Matter, 2010, 6, 5184–5195chondrogenic markers genes, and deposited cartilage ECM
molecules. These results were remarkably improved within the
novel CST constructs. The in vitro performance of the CST
hydrogels generated interesting and promising results that justify
further in vivo studies to give a definitive evaluation towards
a development of a hyaline like tissue.
The overall data shows that chitosan-b-glycerophosphate-
starch hydrogels in combination with adipose derived stromal
cells constitute a promising approach for cartilage regeneration
using a minimal invasive technique.Acknowledgements
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